Race Oncology Limited (ASX:RAC)
Australia · Delayed Price · Currency is AUD 4.250
+0.070 (1.67%)
Oct 17, 2025, 4:10 PM AEST
Race Oncology Market Cap
Race Oncology has a market cap or net worth of 740.59 million as of October 17, 2025. Its market cap has increased by 163.36% in one year.
Market Cap
740.59M
Enterprise Value
726.92M
Revenue
6.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.25
Market Cap Chart
Since July 13, 2016, Race Oncology's market cap has increased from 12.64M to 740.59M, an increase of 5,760.37%. That is a compound annual growth rate of 55.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 740.59M | 215.80% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | 226.55M | 992.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 105.61B |
| Pro Medicus | 29.85B |
| Cochlear | 18.68B |
| Sonic Healthcare | 10.71B |
| Ramsay Health Care | 7.27B |
| Telix Pharmaceuticals | 5.63B |
| Ansell | 4.82B |
| Mesoblast | 3.35B |